Rossari Biotech Ltd Q1 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/53mq1zbrpicgdk73o99t14nt.pdf

Key Takeaways


The Margin Reset: Why 13%-13.5% Is the New Normal

Sunil Chari: "Ankur ji, now, the major business is surfactants at Unitop which was of course planned at Rossari as Ethoxylation earlier, and I think we should consider this as a new normal in terms of EBITDA margins."

Institutional Business: The Long-Gestation Bet

Ketan Sablok: "I have a feeling that this number needs to at least double in the next 2 years and maybe two years down the line we will start seeing some operating leverage flowing in."

Export-Led Volume Growth

Sunil Chari: "we do not want to earn from the freight."

HPPC: Cross-Selling and Product Substitution


Textiles: Price-Led Volume Recovery


Capacity Build-Out and the Reliance Link

Ketan Sablok: "Any new set up which we may plan to do in any other country, we would like to do it through this Dubai subsidiary."

Guidance & Commitments

CommitmentSpecificsTimeline
EBITDA margin range13%-13.5% for the full yearFY25
Institutional business topline₹250 croreFY25
Institutional business margin inflectionOperating leverage to start flowing in once topline reaches ₹500-600 crore~2 years out
Dahej expansion completionAll expansion work finishedBy March 2025
Ethoxylation capacity utilization100% utilization of new capacitiesFY26-27
Export revenue share25%-30% of total revenueNext 2 years
Working capital releaseSome release of funds from working capitalBy September 2024
Textile export tractionGood traction from Bangladesh/Vietnam initiativesH2 FY25 (balance part of year)

Key Metrics

MetricQ1 FY25
Revenue from operations₹489.7 crore, +19.3% YoY from ₹410.6 crore
EBITDA₹64.9 crore, +12.5% YoY from ₹57.7 crore
EBITDA margin13.3%, compared to 14.1% in Q1 FY24; drop due to higher freight, travel, maintenance and selling costs
PAT₹34.9 crore, +19.5% YoY from ₹29.2 crore
HPPC division revenue₹365 crore, +21% YoY from ₹301 crore
Textile Specialty Chemicals revenue₹98 crore, +21% YoY from ₹81 crore
Animal Health and Nutrition revenue₹27 crore, compared to ₹29 crore in Q1 FY24
Revenue mixHPPC 75%, TSC 20%, AHN 5%
Exports share of revenue24%-25%, up from 20% in Q1 FY24; YoY growth close to 50%
Institutional cleaning business revenue₹60 crore for the quarter; full-year FY25 target of ₹250 crore
Ethoxylation capacity utilization90%+ at both Tristar and Unitop; overall average utilization 55%-60%
Cash CAPEX outflow guidance for FY25~₹100 crore, covering Unitop and Rossari expansions plus small AHN vitamin premix and minerals facility
Freight expense increase35%-40% YoY increase over Q1 FY24
One-off other expenses₹3-4 crore, including Tristar plant shutdown maintenance (12-15 days) and HR restructuring consulting